Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy

BACKGROUND/AIMS: Patients with pancreatic cancer (PC) generally have poor clinical outcomes. Early determination of their prognosis is crucial for developing a therapeutic strategy. Recently, various inflammatory markers have been validated as prognostic indicators for many cancers, including PC. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hong Jun, Lee, Suk-young, Kim, Dae Sik, Kang, Eun Joo, Kim, Jung Sun, Choi, Yoon Ji, Oh, Sang Cheul, Seo, Jae Hong, Kim, Jun Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960054/
https://www.ncbi.nlm.nih.gov/pubmed/30360017
http://dx.doi.org/10.3904/kjim.2018.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960054/
https://www.ncbi.nlm.nih.gov/pubmed/30360017
http://dx.doi.org/10.3904/kjim.2018.076

Ejemplares similares